NCT06045325View on ClinicalTrials.gov

Assessment of Measurement Variability Across Automated Biometry Devices

CompletedOBSERVATIONAL
Enrollment

204

Participants

Timeline

Start Date

July 25, 2023

Primary Completion Date

February 16, 2024

Study Completion Date

February 16, 2024

Conditions
Myopia
Interventions
DIAGNOSTIC_TEST

Orbscan II

Diagnostic assessment to measure anterior chamber depth, white-to-white, and corneal thickness.

DIAGNOSTIC_TEST

IOL Master 700

Diagnostic assessment to measure anterior chamber depth, white-to-white, and corneal thickness.

DIAGNOSTIC_TEST

IOL Master 500

Diagnostic assessment to measure anterior chamber depth, white-to-white, and corneal thickness.

DIAGNOSTIC_TEST

Atlas 9000

Diagnostic assessment to measure white-to-white.

DIAGNOSTIC_TEST

Lenstar 900

Diagnostic assessment to measure anterior chamber depth, white-to-white, and corneal thickness.

DIAGNOSTIC_TEST

Pentacam

Diagnostic assessment to measure anterior chamber depth, white-to-white, and corneal thickness.

DIAGNOSTIC_TEST

iTrace

Diagnostic assessment to measure white-to-white and corneal thickness.

DIAGNOSTIC_TEST

Argos

Diagnostic assessment to measure anterior chamber depth, white-to-white, and corneal thickness.

DIAGNOSTIC_TEST

Manual caliper measurement

Manual diagnostic assessment to measure white-to-white.

Trial Locations (1)

77027

Berkeley Eye Center, Houston

All Listed Sponsors
lead

Berkeley Eye Center

OTHER